IBDEI0IU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8468,0)
 ;;=B00.81^^55^540^69
 ;;^UTILITY(U,$J,358.3,8468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8468,1,3,0)
 ;;=3^Herpesviral hepatitis
 ;;^UTILITY(U,$J,358.3,8468,1,4,0)
 ;;=4^B00.81
 ;;^UTILITY(U,$J,358.3,8468,2)
 ;;=^5000478
 ;;^UTILITY(U,$J,358.3,8469,0)
 ;;=B15.9^^55^540^68
 ;;^UTILITY(U,$J,358.3,8469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8469,1,3,0)
 ;;=3^Hepatitis A without hepatic coma
 ;;^UTILITY(U,$J,358.3,8469,1,4,0)
 ;;=4^B15.9
 ;;^UTILITY(U,$J,358.3,8469,2)
 ;;=^5000536
 ;;^UTILITY(U,$J,358.3,8470,0)
 ;;=B16.9^^55^540^5
 ;;^UTILITY(U,$J,358.3,8470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8470,1,3,0)
 ;;=3^Acute hepatitis B w/o delta-agent and without hepatic coma
 ;;^UTILITY(U,$J,358.3,8470,1,4,0)
 ;;=4^B16.9
 ;;^UTILITY(U,$J,358.3,8470,2)
 ;;=^5000540
 ;;^UTILITY(U,$J,358.3,8471,0)
 ;;=B19.10^^55^540^108
 ;;^UTILITY(U,$J,358.3,8471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8471,1,3,0)
 ;;=3^Viral hepatitis B without hepatic coma,unspec
 ;;^UTILITY(U,$J,358.3,8471,1,4,0)
 ;;=4^B19.10
 ;;^UTILITY(U,$J,358.3,8471,2)
 ;;=^5000552
 ;;^UTILITY(U,$J,358.3,8472,0)
 ;;=B18.1^^55^540^47
 ;;^UTILITY(U,$J,358.3,8472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8472,1,3,0)
 ;;=3^Chronic viral hepatitis B without delta-agent
 ;;^UTILITY(U,$J,358.3,8472,1,4,0)
 ;;=4^B18.1
 ;;^UTILITY(U,$J,358.3,8472,2)
 ;;=^5000547
 ;;^UTILITY(U,$J,358.3,8473,0)
 ;;=B17.10^^55^540^6
 ;;^UTILITY(U,$J,358.3,8473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8473,1,3,0)
 ;;=3^Acute hepatitis C without hepatic coma
 ;;^UTILITY(U,$J,358.3,8473,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,8473,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,8474,0)
 ;;=B18.2^^55^540^48
 ;;^UTILITY(U,$J,358.3,8474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8474,1,3,0)
 ;;=3^Chronic viral hepatitis C
 ;;^UTILITY(U,$J,358.3,8474,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,8474,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,8475,0)
 ;;=B18.9^^55^540^49
 ;;^UTILITY(U,$J,358.3,8475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8475,1,3,0)
 ;;=3^Chronic viral hepatitis, unspecified
 ;;^UTILITY(U,$J,358.3,8475,1,4,0)
 ;;=4^B18.9
 ;;^UTILITY(U,$J,358.3,8475,2)
 ;;=^5000550
 ;;^UTILITY(U,$J,358.3,8476,0)
 ;;=A69.20^^55^540^79
 ;;^UTILITY(U,$J,358.3,8476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8476,1,3,0)
 ;;=3^Lyme disease, unspecified
 ;;^UTILITY(U,$J,358.3,8476,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,8476,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,8477,0)
 ;;=A51.0^^55^540^91
 ;;^UTILITY(U,$J,358.3,8477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8477,1,3,0)
 ;;=3^Primary genital syphilis
 ;;^UTILITY(U,$J,358.3,8477,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,8477,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,8478,0)
 ;;=A52.3^^55^540^80
 ;;^UTILITY(U,$J,358.3,8478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8478,1,3,0)
 ;;=3^Neurosyphilis, unspecified
 ;;^UTILITY(U,$J,358.3,8478,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,8478,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,8479,0)
 ;;=A52.9^^55^540^78
 ;;^UTILITY(U,$J,358.3,8479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8479,1,3,0)
 ;;=3^Late syphilis, unspecified
 ;;^UTILITY(U,$J,358.3,8479,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,8479,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,8480,0)
 ;;=A53.9^^55^540^98
 ;;^UTILITY(U,$J,358.3,8480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8480,1,3,0)
 ;;=3^Syphilis, unspecified
 ;;^UTILITY(U,$J,358.3,8480,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,8480,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,8481,0)
 ;;=A54.00^^55^540^64
 ;;^UTILITY(U,$J,358.3,8481,1,0)
 ;;=^358.31IA^4^2
